Navigation Links
Pharmacyclics Reports Updated Clinical Results from its Phase IA Trial of its First in Human Btk-Inhibitor PCI-32765
Date:12/7/2010

rmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medial healthcare needs; and to identify promising product candidates based on exceptional scientific development expertise, develop our products in a rapid, cost-efficient manner and pursue commercialization and/or development partners when and where appropriate. We exist to make a difference for the better and these are important times to do just that.

Presently, Pharmacyclics has four product candidates in clinical development, a clinical development candidate in late stage pre clinical evaluation and several preclinical molecules in lead optimization. We are committed to high standards of ethics, scientific rigor, and operational efficiency as we move each of these programs to viable commercialization. The Company is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com.

NOTE: This announcement may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding our expectations and beliefs regarding our future results or performance. Because these statements apply to future events, they are subject to risks and uncertainties. When used in this announcement, the words "anticipate," "believe," "estimate," "expect," "expectation," "should," "would," "project," "plan," "predict," "intend" and similar expressions are intended to identify such forward-looking statements. Our actual results could differ materially from those projected in the forward-looking statements. Additionally, you should not consider past res
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
2. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
3. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
4. Pharmacyclics Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
5. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
6. Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
7. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
8. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
9. Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
10. Pharmacyclics to Present at Merriman Curhan Fords Investor Summit 2009
11. Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 Apama Medical, a privately ... of next-generation atrial fibrillation technologies, today announced the ... US Patent and Trademark Office (USPTO), titled "Low ... assemblies for use on expandable structures such as ... procedures. "We are grateful to the ...
(Date:6/18/2013)... Calif. , June 18, 2013  Isis Pharmaceuticals, Inc. ... today announced that management will present a general corporate update ... Open House on Tuesday, June 25 at 2:10 p.m. Pacific ... The agenda for the meeting is as follows: 2:00 p.m. ... of record as of April 26, 2013) 2:10 p.m. – ...
(Date:6/17/2013)... , June 17, 2013 Velplex, LLC announced ... a technology platform that connects buyers and sellers of ... an industry leader. Why? It,s because ... are intimately familiar with the dental industry. They have ... and have diligently worked to negotiate some of the ...
Breaking Medicine Technology:Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House 2TopProdeals.com Rises to Top as Discount Dental Supply Leader 2
(Date:6/18/2013)... 19, 2013 oBand Surgery Centers, a ... holding complimentary weight loss seminars in Los Angeles this ... be accessed at their official website. oBand Surgery Centers ... time. Their highly skilled panel of surgeons and dedicated ... , A senior executive working with oBand Surgery Centers ...
(Date:6/18/2013)... As a sponsor of the 2013 Fourth of July Splash, ... Chiropractic want you to get out and celebrate! Dr. Saggau ... are excited to be involved. “My husband and I have lived ... to the Kent Splash event. It's a tradition that our kids ... support this fun day.” , The 2013 Fourth of ...
(Date:6/18/2013)... Chicago, IL (PRWEB) June 18, 2013 Exposed ... is helping thousands of acne suffers of all ages finally ... Unlike other acne treatment products, this new acne clearing system ... current acne, and prevent new acne from forming. ... , ExposedSkinCareReview.org believes these products are some of the most ...
(Date:6/18/2013)... FL (PRWEB) June 19, 2013 "What ... minutes a day could boost your health and well-being? ... Heshelow, founder of Sublime Beauty®. "It is called ... for centuries but became a lost art. Now, people ... know about Skin Brushing, and so do certain health ...
(Date:6/18/2013)... June 19, 2013 Recent studies linking bullying ... bullying-related suicide among young people, led the Centers ... an expert panel to focus on these issues. ... complex relationship between youth involvement in bullying and ... youth is a significant public health problem, with ...
Breaking Medicine News(10 mins):Health News:oBand Surgery Centers Will Hold Complimentary Weight Loss Seminars in Los Angeles in June 2Health News:Lake Meridian Chiropractic of Kent, WA to Sponsor the Fireworks Finale at 15th Annual Fourth of July Splash 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3Health News:The Easiest Way to Contribute to Better Health and Well-Being Starting Today and for Under $20, Says Sublime Beauty® 2Health News:Bullying and suicide among youth is a public health problem 2
... PBCC Announces availability of conference scholarships ... PA Breast Cancer Coalition Annual Conference , , ... to announce the availability of scholarships and travel grants for the 2009 PA Breast ... & Towers on Wednesday, October 14, 2009. , , ...
... , , , ... of octuplets Nadya Suleman and "Jon & Kate Plus 8" has ... in-vitro fertilization (IVF). The recent e.p.t((R)) /BabyCenter ((R)) Fertility ... surveyed believe that public visibility of large families and multiple births ...
... HOUSTON, July 20 What will healthcare look like in the future? ... to learn more and have an opportunity to make your opinions known, please ... a Federal Health Board: The Impact on Texas." , ... 1401 St. Joseph Parkway in Houston, Texas on Wednesday, July 22. All ...
... , SEOUL, South Korea, July 20 ... to announce that its wholly owned subsidiary, VASKA, a ... institutional, and consumer markets, has successfully turned the first major commercial ... Royal Laundry of South San Francisco is the largest ...
... , , , CARY, ... a specialty pharmaceutical company focused on acquiring, developing and commercializing ... that David Price, Executive Vice President, Finance, and Chief Financial ... of the Year in the Small Public Business category. ...
... , , CARLSBAD, Calif., July 20 ... manufacturer, recently introduced a new advanced lens design for ... takes advantage of the best features of the hybrid ... comfort. The patent-pending design is optimized to vault the ...
Cached Medicine News:Health News:Scholarships Available for PA Breast Cancer Coalition Annual Conference 2Health News:New e.p.t.(R)/BabyCenter(R) Fertility Report Reveals 70 Percent of Moms Want Tighter Regulation on In-Vitro Fertilization 2Health News:New e.p.t.(R)/BabyCenter(R) Fertility Report Reveals 70 Percent of Moms Want Tighter Regulation on In-Vitro Fertilization 3Health News:New e.p.t.(R)/BabyCenter(R) Fertility Report Reveals 70 Percent of Moms Want Tighter Regulation on In-Vitro Fertilization 4Health News:Building a Federal Health Board - Impact on Texas 2Health News:HepaHope Korea Subsidiary VASKA Introduces Green Chemicals to U.S. Commercial Laundry Industry 2Health News:Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal 2Health News:SynergEyes, Inc. Launches New Hybrid Lens Design for Keratoconus Patients 2Health News:SynergEyes, Inc. Launches New Hybrid Lens Design for Keratoconus Patients 3
... The Clariflex® Intraocular Lens is indicated ... years of age or older in whom ... IOL is a third-generation IOL design made ... is designed both to reduce internal reflections ...
... Lenses: The Bausch & Lomb PMMA Posterior Chamber ... primary implantation for the visual correction of aphakia ... where a cataractous lens has been removed by ... be placed in the ciliary sulcus or capsular ...
... USIOL lenses are manufactured using ... processes. Perspex CQ UV PMMA ... multi-piece and single piece lenses. ... in both nonphaco and phaco ...
... II is a sterile nonpyrogenic, transparent viscoelastic ... II contains 12 mg/ml of high molecular ... hyaluronate dissolved in physiological saline. In the ... is 105,000 cps (105 Pa s) at ...
Medicine Products: